Article

Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis.

Department of Gene and Cell Medicine, and the Immunology Institute, 1425 Madison Avenue, Mount Sinai School of Medicine, New York 10029, USA.
Current Opinion in Lipidology (Impact Factor: 5.8). 11/2008; 19(5):462-8. DOI: 10.1097/MOL.0b013e32830d5f09
Source: PubMed

ABSTRACT This review compares the fate of monocyte-derived cells that enter atherosclerotic plaques with those that accumulate at other sites of inflammation.
Resolution of inflammatory reactions involves emigration of monocyte-derived cells out of the inflamed site through nearby lymphatic vessels. However, this emigratory process associated with resolution is impaired in atherosclerosis. The mechanism for impeded emigration from plaques in vivo remains to be determined, but multiple factors are likely involved, including specialized properties of artery walls and a negative impact of lipid mediators on monocyte-derived cell migration.
Impaired egress would be expected to compound macrophage accumulation within plaques, contribute to build-up of necrotic pools, and explain in part the reticence of many plaques to regress, or resolve. Restoration of the capacity of monocyte-derived cells to leave plaques would, by contrast, be expected to facilitate regression, but it remains to be determined whether restoring egress may sometimes provoke unwanted outcomes as well.

0 Bookmarks
 · 
60 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: HDL carries biologically active lipids such as sphingosine-1-phosphate (S1P) and stimulates a variety of cell signaling pathways in diverse cell types, which may contribute to its ability to protect against atherosclerosis. HDL and sphingosine-1-phosphate receptor agonists, FTY720 and SEW2871 triggered macrophage migration. HDL-, but not FTY720-stimulated migration was inhibited by an antibody against the HDL receptor, SR-BI, and an inhibitor of SR-BI mediated lipid transfer. HDL and FTY720-stimulated migration was also inhibited in macrophages lacking either SR-BI or PDZK1, an adaptor protein that binds to SR-BI's C-terminal cytoplasmic tail. Migration in response to HDL and S1P receptor agonists was inhibited by treatment of macrophages with sphingosine-1-phosphate receptor type 1 (S1PR1) antagonists and by pertussis toxin. S1PR1 activates signaling pathways including PI3K-Akt, PKC, p38 MAPK, ERK1/2 and Rho kinases. Using selective inhibitors or macrophages from gene targeted mice, we demonstrated the involvement of each of these pathways in HDL-dependent macrophage migration. These data suggest that HDL stimulates the migration of macrophages in a manner that requires the activities of the HDL receptor SR-BI as well as S1PR1 activity.
    PLoS ONE 09/2014; 9(9):e106487. DOI:10.1371/journal.pone.0106487 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Chronic, low-grade adipose tissue inflammation is a key etiological mechanism linking the increasing incidence of type 2 diabetes (T2D) and obesity. It is well recognized that the immune system and metabolism are highly integrated, and macrophages, in particular, have been identified as critical effector cells in the initiation of inflammation and insulin resistance. Recent advances have been made in the understanding of macrophage recruitment and retention to adipose tissue and the participation of other immune cell populations in the regulation of this inflammatory process. Here we discuss the pathophysiological link between macrophages, obesity, and insulin resistance, highlighting the dynamic immune cell regulation of adipose tissue inflammation. We also describe the mechanisms by which inflammation causes insulin resistance and the new therapeutic targets that have emerged.
    Immunity 07/2014; 41(1):36-48. DOI:10.1016/j.immuni.2014.05.010 · 19.75 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Part of the symposium on Nanostructured Materials at the Fourth International Congress on Ceramics (ICC4) dealt with health aspects related to these materials. Major issues discussed included definitions and measurements of nanoparticles, best test protocols, collaboration and communication between, for example, materials scientists and biologists, and the plethora of information and regulations (that is sometimes even conflicting). Emerging opportunities were identified in terms of obtaining uniformity of nomenclature and testing standards, education and training of a new generation of multidisciplinary researchers, and understanding and then fully exploiting the positive aspects of nanomaterials, including improvements to human health.
    International Journal of Applied Ceramic Technology 07/2013; 10(4). DOI:10.1111/ijac.12079 · 1.22 Impact Factor

Full-text (2 Sources)

Download
12 Downloads
Available from
May 20, 2014